This study was limited in scope: Conducted on 24 rats, not humans Administered a single dose Designed only to demonstrate that some absorption is possible Importantly, the study itself includes this disclaimer: This proof-of-concept study is not intended to provide guidance on the sublingual dosing of semaglutide in humans, or dosing conversion from other forms to sublingual administration. This means the only research behind these products cannot confirm whether they work in humans or provide guidance on appropriate dosing
It also may help you lose weight indirectly, because it can improve sleep, which makes it easier for people to maintain lifestyle changes like eating a healthier diet and being more active, she explains
Search for a doctor or hospital in your network
GLP-1 medications can help manage blood sugar levels, reduce appetite, and support weight loss
Who Benefits Most From GLP-1 Treatment and How to Set Realistic Expectations GLP-1 medications are indicated for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition (hypertension, type 2 diabetes, cardiovascular disease, or sleep apnea)
While some preclinical studies suggest GLP-1 receptor agonists may have anti-inflammatory properties, it is important to emphasise that there is no clinical evidence demonstrating benefit in fibromyalgia patients